MedPath
HSA Approval

K. U. DOXORUBICIN HCL FOR INJECTION 50 mg/vial

SIN10991P

K. U. DOXORUBICIN HCL FOR INJECTION 50 mg/vial

K. U. DOXORUBICIN HCL FOR INJECTION 50 mg/vial

June 26, 1999

SHOEI UNIVERSAL CORPORATION PTE LTD

SHOEI UNIVERSAL CORPORATION PTE LTD

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantSHOEI UNIVERSAL CORPORATION PTE LTD
Licence HolderSHOEI UNIVERSAL CORPORATION PTE LTD

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

INJECTION, POWDER, FOR SOLUTION

INTRAVENOUS

Medical Information

L01DB01

doxorubicin

Manufacturer Information

SHOEI UNIVERSAL CORPORATION PTE LTD

KOREA UNITED PHARMACEUTICAL INC

Active Ingredients

DOXORUBICIN HCl EQV DOXORUBICIN

50 mg/vial

Doxorubicin

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

K. U. DOXORUBICIN HCL FOR INJECTION 50 mg/vial - HSA Approval | MedPath